← Back to contracts

Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV

US · IL National Institutes of Health (NIH) grant unknown #nih-5R01HL174066-02

Summary

This NIH research project investigates the mechanisms by which HIV-associated extracellular vesicles containing the Nef protein (Nef EVs) contribute to accelerated atherosclerosis in people living with HIV (PLWH). The study uses a systems biology approach combining multi-omics, data integration, and network analysis to profile macrophage heterogeneity and function. The central hypothesis is that Nef EVs impair efferocytosis (the clearance of dead cells by macrophages), shifting macrophage populations toward an atherogenic phenotype and promoting high-risk atherosclerotic plaque formation. Findings are intended to identify novel therapeutic targets for cardiovascular disease in long-term HIV survivors.

What they want

The project is organized into three Specific Aims: (1) Systems-based macrophage profiling using unbiased multi-omics, data integration, and network analysis to identify novel mechanisms of macrophage activation by Nef EVs; (2) In vitro and in vivo validation of omics data to address underlying mechanisms for impaired macrophage efferocytosis by Nef EVs; (3) A third Specific Aim is implied but not described in the provided excerpt. The overall approach examines the effects of Nef-containing extracellular vesicles on macrophage heterogeneity, subpopulation balance, and atherogenic plaque formation in the context of HIV infection.
Deliverables
  • Systems-based macrophage profiling using multi-omics and network analysis
  • In vitro validation of Nef EV-impaired efferocytosis mechanisms
  • In vivo validation of Nef EV-impaired efferocytosis mechanisms
  • Identification of novel therapeutic targets for HIV-associated vascular disease
  • Research data outputs from multi-omics experiments
Technical requirements
  • Multi-omics data generation and analysis (transcriptomics, proteomics, and/or metabolomics)
  • Systems biology / network analysis methodologies
  • In vitro macrophage culture and functional assays
  • In vivo animal model experimentation
  • Bioinformatics and data integration capabilities
  • Extracellular vesicle (EV) isolation and characterization
  • Efferocytosis assay expertise

Risks & flags

  • Highly specialized scope (Nef EVs, efferocytosis in HIV) strongly suggests a single investigator/lab with preliminary data already in hand
  • Preliminary multi-omics data already cited, indicating incumbent research team advantage
  • Three Specific Aims structure is consistent with an NIH R01-type award likely written around a specific PI's existing research program

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Nef in impaired efferocytosis: a novel mec…
$unknown
Onboard